martes, 30 de julio de 2019

The Pfizer-Mylan deal is not quite as it appears - STAT

The Pfizer-Mylan deal is not quite as it appears - STAT

Daily Recap

The Pfizer-Mylan deal is not quite as it appears

By MATTHEW HERPER


RUBY WALLAU FOR STAT
It’s easy to see what Mylan investors like about the newly announced deal. But they might not like what could come later on.

No hay comentarios:

Publicar un comentario